SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001494650-21-000137
Filing Date
2021-11-18
Accepted
2021-11-18 12:20:56
Documents
22
Period of Report
2021-11-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K optn-20211118.htm   iXBRL 8-K 45561
2 EX-1.1 underwritingagreement.htm EX-1.1 309479
3 EX-5.1 hoganopinion.htm EX-5.1 25155
4 EX-99.1 pressrelease111521.htm EX-99.1 9662
5 EX-99.2 pressrelease111621.htm EX-99.2 10162
6 EX-99.3 pressrelease111821.htm EX-99.3 9258
10 image.jpg GRAPHIC 67437
11 image1.jpg GRAPHIC 8070
12 image2.jpg GRAPHIC 67437
13 imageb.jpg GRAPHIC 67437
14 optn-20211118_g1.jpg GRAPHIC 10067
  Complete submission text file 0001494650-21-000137.txt   957768

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optn-20211118.xsd EX-101.SCH 1902
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT optn-20211118_lab.xml EX-101.LAB 26951
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optn-20211118_pre.xml EX-101.PRE 14146
15 EXTRACTED XBRL INSTANCE DOCUMENT optn-20211118_htm.xml XML 12981
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 211423382
SIC: 2834 Pharmaceutical Preparations